| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 02/18/2010 | US20100041640 Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 02/18/2010 | US20100041555 3-Phenoxy-4-pyridazinol derivatives and herbicidal composition containing the same |
| 02/18/2010 | US20100041163 Molecular structure is that of coumarin moiety coupled to quaternary ammonium heterocycle through a vinyl or polyvinyl linkage; demonstrates ability to associate with proteins in a non-covalent, non-specific manner at low pH, where associated form displays significantly higher fluorescence emission |
| 02/18/2010 | US20100039688 6-(biphenyl-ester)-3h-naphtho[2,1-b]pyrans as photochromic dichroic dyes and optical article containing them |
| 02/17/2010 | EP2154130A1 Pyridone compound |
| 02/17/2010 | EP2153832A2 Heterocyclic aspartyl protease inhibitors |
| 02/17/2010 | EP2152698A1 Improved synthesis of (2s-cis)-2-(bromomethyl)-2-(4-chlorophenyl)-1,3 dioxolane-4-methanol methanesulfonate(ester) |
| 02/17/2010 | EP2152697A2 Process for the preparation of alfuzosin and salts thereof |
| 02/17/2010 | EP2152674A1 Benzimidazolone chymase inhibitors |
| 02/17/2010 | EP2152671A1 Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders |
| 02/17/2010 | EP2152664A1 Dipeptide analogs as coagulation factor inhibitors |
| 02/17/2010 | EP2152272A2 Novel 2,3-diamino-quinazolinone derivatives and their medical use |
| 02/17/2010 | EP1347950B1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
| 02/17/2010 | CN101648947A 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
| 02/17/2010 | CN101648944A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 02/16/2010 | US7662977 Such as 2-cationic amino-4-oxo-chromene derivatives; water solubility, pharmacokinetics; reduced side effects; anticancer agents |
| 02/16/2010 | US7662938 2′-fluoronucleosides |
| 02/16/2010 | US7662845 2,5-Dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12 |
| 02/16/2010 | US7662839 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders; e.g. {4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl}-acetic acid |
| 02/16/2010 | US7662825 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma |
| 02/16/2010 | US7662824 (S)-4-Bromo-3-[(2-2,3-dihydro-benzofuran-5-yl-acetyl)-hydrazono]-2-oxo-2,3-dihydro-1H-indole-6-carboxylic acid [3-(2-hydroxymethyl-pyrrolidin-1-yl)-propyl]-amide; for treating conditions such as cancers and other cell proliferative disorders |
| 02/16/2010 | US7662818 e.g. 4-[5-(piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; and multiple sclerosis |
| 02/16/2010 | US7662811 1,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of use |
| 02/16/2010 | CA2571627C Substituted aryl-amine derivatives and methods of use |
| 02/16/2010 | CA2537414C .beta. crystalline form of ivabradine chlorhydrate, process for the preparation thereof and pharmaceutical compounds containing it |
| 02/16/2010 | CA2452918C New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
| 02/16/2010 | CA2450922C Piperidines for use as orexin receptor antagonists |
| 02/16/2010 | CA2438961C Beta-lactam compounds, manufacturing methods of the compounds and serum hypocholesterolemic agents containing the compounds |
| 02/16/2010 | CA2407043C Naphthamidine urokinase inhibitors |
| 02/16/2010 | CA2385938C Cyclic amine compounds as ccr5 antagonists |
| 02/16/2010 | CA2341707C Pyrimidine derivatives |
| 02/11/2010 | WO2010017545A2 Triazole compounds that modulate hsp90 activity |
| 02/11/2010 | WO2010017479A1 Triazole compounds that modulate hsp90 activity |
| 02/11/2010 | WO2010017401A1 Bi-1h-benzimidazoles as hepatitis c virus inhibitors |
| 02/11/2010 | WO2010017387A2 Lapatinib intermediates |
| 02/11/2010 | WO2010017323A1 Novel methylenedioxy phenolic compounds and their use to treat disease |
| 02/11/2010 | WO2010017120A1 Cyclopropylchromene derivatives as modulators of the alpha-2c receptor |
| 02/11/2010 | WO2010016549A1 Tricyclic compound |
| 02/11/2010 | WO2010015681A1 Fungicidal n-(2-pyridylpropyl)carboxamide derivatives and their oxa, aza and thia analogues |
| 02/11/2010 | WO2010015447A1 Angiotensin ii receptor antagonists |
| 02/11/2010 | US20100035932 Novel formyl peptide receptor like 1 agonists that induce macrophage tumor necrosis factor alpha and computational structure-activity relationship analysis of thereof |
| 02/11/2010 | US20100035912 Small Molecule Inhibitors of Retroviral Assembly and Maturation |
| 02/11/2010 | US20100035849 Novel methylenedioxy phenolic compounds and their use to treat disease |
| 02/11/2010 | CA2733430A1 Novel methylenedioxy phenolic compounds and their use to treat disease |
| 02/10/2010 | EP2151439A1 Nitrogenated aromatic 6-membered ring derivative, and pharmaceutical agent comprising the same |
| 02/10/2010 | EP2151435A1 Pharmaceutical composition for treatment of alzheimer's disease |
| 02/10/2010 | EP2150255A1 Quinoxaline derivatives as p13 kinase inhibitors |
| 02/10/2010 | EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/10/2010 | EP1701951B1 Modulators of peripheral 5-ht receptors |
| 02/10/2010 | CN101643470A Alkyl ether derivatives or salts thereof |
| 02/10/2010 | CN100588655C Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 02/09/2010 | US7659305 4-carbo- or heterocyclic alkyl-, oxy-, amino-, and thio-substituted; e.g., 2S, 4S)-4-(3-Chloro-phenoxy)-pyrrolidine-2-carboxylic acid; controlling neurotransmitter release; uses include general treatment of pain, particularly neuropathic pain. |
| 02/09/2010 | US7659272 N-[phenyl or heteroaryl carbonoyl pyridyl] arylsulfonamides; antiinflammatory, antianaphylactic agents; transplant rejection, gastointestinal, respriatory system and skin disorders |
| 02/09/2010 | US7659268 Modulators of ATP-binding cassette transporters |
| 02/09/2010 | CA2625906C Lazaroids-based compositions and methods for preventing adhesion formation using the same |
| 02/09/2010 | CA2484954C 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 02/09/2010 | CA2430673C N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization |
| 02/09/2010 | CA2299754C Hydroxy-substituted n-alkoxy hindered amines |
| 02/09/2010 | CA2274201C Di-or triaza-spiro[4,5]decane derivatives |
| 02/09/2010 | CA2268403C Anthranilic acid derivatives as multi drug resistance modulators |
| 02/09/2010 | CA2201863C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors |
| 02/09/2010 | CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 02/04/2010 | WO2010014883A2 Azacitidine process and polymorphs |
| 02/04/2010 | WO2010014611A1 Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds |
| 02/04/2010 | WO2010013595A1 (5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative |
| 02/04/2010 | WO2010013222A1 Pyrrole carboxylic acid derivatives as antibacterial agents |
| 02/04/2010 | WO2010012442A2 Insecticidal benzenedicarboxamide derivative |
| 02/04/2010 | WO2010012397A1 N-(indol-3-ylalkyl)(hetero)arylamide derivatives as modulators of the ep2 receptor |
| 02/04/2010 | WO2010012396A1 5,6 substituted benzamide derivatives as modulators of the ep<sb>2 </sb>receptor |
| 02/04/2010 | WO2009129267A3 Small molecule inhibitors of the pleckstrin homology domain and methods for using same |
| 02/04/2010 | US20100029919 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 02/04/2010 | US20100029705 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis |
| 02/04/2010 | US20100029699 Matrix metalloproteinase inhibitors |
| 02/04/2010 | US20100029668 Novel pyridazine derivatives |
| 02/04/2010 | US20100029667 Spray dried formulation |
| 02/04/2010 | US20100029620 Substituted triazoline, tetrazolone and imidazolone derivatives for use as a medicine |
| 02/04/2010 | US20100029607 Substituted Piperazines as CB1 Antagonists |
| 02/04/2010 | US20100029010 Diaminorhodamine Derivative |
| 02/04/2010 | CA2732618A1 Pyrrole carboxylic acid derivatives as antibacterial agents |
| 02/04/2010 | CA2731358A1 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
| 02/04/2010 | CA2731323A1 Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds |
| 02/03/2010 | EP2149572A1 Melamine epoxides |
| 02/03/2010 | EP2149567A1 Cyclic polyamines for binding phosphatidylserine |
| 02/03/2010 | EP2149561A1 Tetrahydroisoquinolin-1-one derivative or salt thereof |
| 02/03/2010 | EP2149552A1 5,6 substituted benzamide derivatives as modulators of EP2 receptors |
| 02/03/2010 | EP2149551A1 N-(indol-3-ylalkyl)-(hetero)arylamid derivatives as modulators of EP2 receptors |
| 02/03/2010 | EP2149550A1 Nitrogen-containing five-membered heterocyclic compound |
| 02/03/2010 | EP2148876A1 Pyrazolone derivatives as pde4 inhibitors |
| 02/03/2010 | EP2148874A1 Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors |
| 02/03/2010 | EP2148871A1 Quinoline-carboxamide derivatives as p2y12 antagonists |
| 02/03/2010 | EP2148868A1 Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators |
| 02/03/2010 | EP2148862A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk |
| 02/03/2010 | EP2148857A1 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists |
| 02/03/2010 | EP1778677B1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/03/2010 | CN101641350A Dibenzo[b,f][1,4]oxazapine compounds |
| 02/03/2010 | CN100586945C Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/03/2010 | CN100586927C Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 02/02/2010 | US7655808 Leptomycin B; antiproliferative agents; antitumor agents; antcarcinogenic agents; inhibiting the export of a protein from the nucleus of a cell via a CRM1-mediated process; tissue-targeted therapy; cancer of human breast, lung, ovaries, prostate, and bladder, and leukemia cell |
| 02/02/2010 | US7655804 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 02/02/2010 | US7655802 Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs |